Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01990079 · ClinicalTrials.gov registry record · NA
Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01990079 is a NA study that has completed, run by Duke University. The registered enrollment target is 15 participants.
The verdict
NCT01990079, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The primary goal of the study is to evaluate the use of a new smart phone application in preventing relapse to smoking among people with PTSD. The technology intervention will combine a mobile system to reward non-smoking, smoking cessation counseling, smoking cessation medications, and use of the smart phone app. The primary aim is to evaluate how effective this intervention is in preventing smoking relapse compared to another intervention that does not include the app.
Interventions
- DRUG Bupropion
- DRUG nicotine replacement therapy
- OTHER Smoking cessation counseling
- BEHAVIORAL mobile contingency management
- OTHER Stay Quit Coach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01990079
The ClinicalTrials.gov registry entry for NCT01990079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Bupropion is the first listed.
NCT01990079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01990079 about?
NCT01990079 is a clinical study titled "Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD". The primary goal of the study is to evaluate the use of a new smart phone application in preventing relapse to smoking among people with PTSD. The technology intervention will combine a mobile system to reward non-smoking, smoking cessation counseling, smoking cessation medications, and use of the s...
What is the current status of trial NCT01990079?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2013-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01990079?
The interventions under investigation include: Bupropion (DRUG), nicotine replacement therapy (DRUG), Smoking cessation counseling (OTHER), mobile contingency management (BEHAVIORAL), Stay Quit Coach (OTHER).
Who is sponsoring clinical trial NCT01990079?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.